Alyeska Investment Group, L.P. - 31 Mar 2025 SCHEDULE 13G Report for Aligos Therapeutics, Inc. Common Stock, par value, $0.0001 per share (ALGS)

Filing Manager
Alyeska Investment Group, L.P.
Reporting Manager
Alyeska Investment Group, L.P.
Security
Aligos Therapeutics, Inc. Common Stock, par value, $0.0001 per share
Symbol
ALGS
Shares outstanding
5,305,305 shares
Disclosed Ownership
530,000 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
15 May 2025, 16:20:55 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alyeska Investment Group, L.P. 10% 530,000 0 530,000 Jason Bragg Jason Bragg | Chief Financial Officer
Alyeska Fund GP, LLC 10% 530,000 0 530,000 Jason Bragg Jason Bragg | Chief Financial Officer
Anand Parekh 10% 530,000 0 530,000 Anand Parekh Anand Parekh | Self